| Sources | Names Used |
|---|---|
| CTRPv2 | selumetinib:PLX-4032 (8:1 mol/mol) |
| PharmacoGx | selumetinib:PLX-4032 (8:1 mol/mol) |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | DNA2 | CTRPv2 | pan-cancer | AAC | -0.2 | 6e-08 |
| mRNA | FAM120C | CTRPv2 | pan-cancer | AAC | -0.19 | 6e-08 |
| mRNA | ASB3 | CTRPv2 | pan-cancer | AAC | -0.2 | 6e-08 |
| mRNA | ERBB3 | CTRPv2 | pan-cancer | AAC | 0.23 | 6e-08 |
| mRNA | WASF1 | CTRPv2 | pan-cancer | AAC | -0.21 | 6e-08 |
| mRNA | FMN1 | CTRPv2 | pan-cancer | AAC | 0.22 | 6e-08 |
| mRNA | GSDMA | CTRPv2 | pan-cancer | AAC | 0.19 | 7e-08 |
| mRNA | GALE | CTRPv2 | pan-cancer | AAC | 0.21 | 7e-08 |
| mRNA | USP30 | CTRPv2 | pan-cancer | AAC | -0.19 | 7e-08 |
| mRNA | CATSPER1 | CTRPv2 | pan-cancer | AAC | 0.19 | 8e-08 |
